The Motley Fool Previous Page

For "Hemlock Grove," the Path to Success Is Easier Than You Might Think

Tim Beyers
April 20, 2013

Netflix's (NASDAQ: NFLX) new horror show Hemlock Grove, which makes its debut this weekend, has already come under fire from some reviewers. The negative press appears to be emboldening the bears ahead of the company's April 22 earnings report. They might be acting prematurely.

Look at history. HBO's comparable horror series, True Blood, captured just 1.4 million viewers in its September 2008 premiere before going on to five seasons of award-winning performances and excel